Classic psychedelics in the treatment of substance use disorder
Potential synergies with twelve-step programs
Bibliographic Data
| ID | 14908951 |
|---|---|
| Authors | David B Yaden (0000-0002-9604-6227, Johns Hopkins Medicine, corresponding author), Andrea P Berghella, Andrea Berghella (0000-0002-8666-0119, Johns Hopkins University), Paul S Regier (0000-0002-7942-1654, University of Pennsylvania), Albert Garcia-Romeu, Albert Garcia‐Romeu (0000-0003-2182-1644, Johns Hopkins University), Matthew W Johnson (0000-0002-3741-6312, Johns Hopkins University), Peter S Hendricks (University of Alabama at Birmingham) |
| Year | 2021 |
| Volume | 98 |
| Pages | 103380 |
| Publication date | 2021-12-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Drug Policy (JOURNAL) |
| Journal identifiers | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2021.103380 |
| PMID | 34329952 |
| OpenAlex | W3186114733 |
| Language | EN |
| Citations received | 10 |
| References cited | 76 |
Addiction · Alcoholics Anonymous · Hallucinogen · Psilocybin · Psychiatry · Psychotherapist · Chemical synthesis and alkaloids · Clinical Psychology · Neurotransmitter Receptor Influence on Behavior · Psychedelics and Drug Studies · Psychology
Psychedelics and workplace harm
Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder
MDMA-assisted psychotherapy; Inclusion of transgender and gender diverse people in the frontiers of PTSD treatment trials
Psychedelic Augmentation of 12-Step Engagement
Religion, Psychedelics, Risky Behavior, and Violence
Religious Social Integration, Psychedelics, and Psychological Distress
Supporting desistance from crime
Can psychedelic-assisted psychotherapy play a role in enhancing motivation to change in addiction treatment settings
Psychedelics, attachment, and enculturation dynamics
Minorities' Diminished Psychedelic Returns
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer
Cessation and reduction in alcohol consumption and misuse after psychedelic use
Survey study of challenging experiences after ingesting psilocybin mushrooms
Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction
Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin
Psilocybin-Occasioned Mystical Experiences in the Treatment of Tobacco Addiction
Psilocybin with psychological support for treatment-resistant depression
Classic psychedelics
Lysergic acid diethylamide (LSD) for alcoholism
Critical Literature Review on the Definition Clarity of the Concept of Faith, Religion, and Spirituality
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
Dropout rates of in‐person psychosocial substance use disorder treatments
Human hallucinogen research
Treatment Access Barriers and Disparities Among Individuals with Co-Occurring Mental Health and Substance Use Disorders
Ayahuasca-Assisted Therapy for Addiction
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
Survey of subjective "God encounter experiences"
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression
The development of the Awe Experience Scale (AWE-S)
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression
Medication-Assisted Treatment of Opioid Use Disorder
Researching the spiritual dimensions of alcohol and other drug problems
Drug harms in the UK
Long-term follow-up of psilocybin-facilitated smoking cessation
Psilocybin with psychological support for treatment-resistant depression
Psychedelics
Trial of Psilocybin versus Escitalopram for Depression
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
Psilocybin occasioned mystical-type experiences
Psilocybin-assisted treatment for alcohol dependence
The role of spirituality and religiousness in aiding recovery from alcohol and other drug problems
Beyond beliefs
Mysticism and Drugs
A Controlled Study of Lysergide in the Treatment of Alcoholism. I . The Effects on Drinking Behavior
Lysergide Treatment of Schizophrenic and Nonschizophrenic Alcoholics; A Controlled Evaluation
Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use
The tripping point
Hallucinogens and Redemption
Short-Term Treatment Effects of a Substance Use Disorder Therapy Involving Traditional Amazonian Medicine
Of Roots and Fruits
The Varieties of Self-Transcendent Experience
| Unique citing works | 10 |
|---|---|
| Citations per year | 2,5 |
| Citation span | 2022 - 2025 (4) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 10 |